News & Analysis as of

Medical Supplies Section 301

Braumiller Law Group, PLLC

Hot Topics in International Trade - June 2024- Summary of the Findings of the USTR Four-Year Review of Actions Taken in the...

On May 14, 2024, the United States Trade Representative (USTR) released its Final Report relating to the four-year review of actions taken in the Section 301 investigation. Within the Report, the USTR confirmed that it...more

Foley Hoag LLP

USTR Seeking Public Comments on Proposed Tariff Increases on Chinese Goods

Foley Hoag LLP on

As reported in our previous client alert, on May 14, 2024, President Biden announced that he directed his Trade Representative to increase tariffs under Section 301 of the Trade Act of 1974 (Section 301) on a wide range of...more

Baker Donelson

Certain Health Care Products Could Have Section 301 Duties Reinstated

Baker Donelson on

The United States Trade Representative (USTR) is likely to reinstate Section 301 tariffs on 81 COVID pandemic-related products. The 81 health care products that will be affected include, but are not limited to, these items: ...more

White & Case LLP

USTR Extends Section 301 Tariff Exclusions for Medical Products; Further Tariff Relief Under Consideration

White & Case LLP on

On May 27, 2022, the Office of the US Trade Representative (USTR) published a Federal Register notice extending Section 301 tariff exclusions for certain China-origin medical products needed to address the COVID-19 pandemic....more

McDermott Will & Emery

New Public-Comment Period Regarding Section 301 Tariffs Impacting Certain Medical-Care and COVID-19 Response Products

McDermott Will & Emery on

As the country continues to experience the effects of the COVID-19 pandemic, the Office of the US Trade Representative (USTR) has invited public comments on whether to continue excluding certain medical supplies from the...more

Kelley Drye & Warren LLP

USTR Extends Tariff Exclusions for Products from China Needed to Combat COVID-19

On March 10, 2021, the United States Trade Representative (USTR) published an extension of the COVID-19 related medical-care and response product exclusions from Section 301 duties covering imports from China. The agency...more

Sheppard Mullin Richter & Hampton LLP

USTR Grants New Section 301 Exclusions and Extends Existing Exclusions for Certain Chinese Medical Products

On December 29, 2020, the U.S. Trade Representative (USTR) posted a notice granting new Section 301 product exclusions and extending existing exclusions for COVID-19 medical care products. This action is in response to USTR’s...more

Akin Gump Strauss Hauer & Feld LLP

Executive Order on Essential Medicines: A Timeline and Overview of Key Provisions

On August 6, President Trump issued an Executive Order (EO) titled “Ensuring Essential Medicines, Medical Countermeasures and Critical Inputs Are Made in the United States.” The far-reaching EO seeks to ensure the domestic...more

Bradley Arant Boult Cummings LLP

Trade Agreements and COVID-19: New Medical Supply Tariff Exclusions

Since June 20, 2018, the U.S. has taken multiple tariff actions against China under Section 301 of the Trade Act. In total, these tariffs affect products with a total annual trade value of $550 billion. In a previous alert,...more

Holland & Knight LLP

Comments Sought on Section 301 Exclusions for China Imports Related to COVID-19

Holland & Knight LLP on

The Office of the U.S. Trade Representative (USTR) has issued a call for comments regarding the possible removal of Section 301 tariffs for medical-care products from China. The request for comments on the easing of Section...more

Foley & Lardner LLP

USTR Grants Section 301 Exclusions for Chinese-Origin Medical Supplies Needed in the Coronavirus Fight and Establishes Procedures...

Foley & Lardner LLP on

Many U.S. manufacturers that rely on Chinese-origin goods have been paying steep tariffs of up to 25% on the import of Chinese goods due to special Section 301 tariffs. Because these tariffs were applied to the vast majority...more

Hogan Lovells

USTR invites comments on potential Section 301 exclusions in response to the coronavirus

Hogan Lovells on

The Office of the U.S. Trade Representative (USTR) has announced it is accepting comments on potential Section 301 tariff exclusions for Chinese imports necessary to respond to the coronavirus. USTR is likely to expeditiously...more

Husch Blackwell LLP

USTR Announces New Section 301 Product Exclusions For List 4

Husch Blackwell LLP on

On March 25, 2020, the United States Trade Representative (“USTR”) issued new product exclusions pertaining to the 7.5% Section 301 List 4A Tariffs. The new list of exclusions includes five 10-digit HTS subheadings and seven...more

Polsinelli

USTR Accepting Comments for Medical-Care Products to be Removed from Section 301 Actions due to COVID-19 Outbreak

Polsinelli on

On March 25, 2020, the Office of the U.S. Trade Representative (USTR) published a Federal Register Notice requesting public comments on possible further modifications to remove Section 301 duties from additional...more

ArentFox Schiff

COVID-19 Impact on Section 301 China Tariffs: USTR Excludes Some Healthcare Products, Solicits Requests to Exclude More

ArentFox Schiff on

On Wednesday, March 25, 2020, the U.S. Trade Representative (USTR) published a Federal Register notice requesting comments on the removal of Section 301 tariffs from Chinese medical-care products—including those that have...more

Pillsbury - Global Trade & Sanctions Law

USTR Launches New Exclusion Request Procedure to Address COVID-19

On Friday, March 20, 2020, in an effort to fight against the coronavirus pandemic, the U.S. Trade Representative (USTR) announced that it is accepting exclusions requests to remove tariffs imposed on Chinese origin...more

Polsinelli

Updated Section 301 Granted Exclusions for Chinese Goods Including Medical Goods and Equipment — Trade Compliance

Polsinelli on

The Office of the U.S. Trade Representative (USTR) recently published several Federal Register Notices (March 10, 16, and 17, 2020) announcing new granted exclusions for List 3 goods (currently 25 percent) and List 4A goods...more

Kelley Drye & Warren LLP

USTR Considers Removal of 301 Duties on COVID-19-Related Medical Care Products

In response to the COVID-19 outbreak, USTR issued a Federal Register Notice requesting public comments on the possibility of removing the application of China Section 301 duties from medical care products, including inputs...more

Akerman LLP

USTR Issues Notices to U.S. Importers Related to U.S.-China Trade War Amid Coronavirus Spread

Akerman LLP on

The Office of the U.S. Trade Representative (USTR) has issued two separate notices of interest to U.S. importers caught in the U.S.-China trade war and that are seeking relief through Section 301 tariff exclusions....more

Akin Gump Strauss Hauer & Feld LLP

USTR Requests Comments on Section 301 Tariffs on COVID-19 Related Products

- Late on Friday, March 20, 2020, USTR announced that it has opened a new public comment period for businesses and government agencies to request additional product exclusions from Section 301 duties for certain...more

Husch Blackwell LLP

USTR Announces New Section 301 Product Exclusions For Medical Supplies

Husch Blackwell LLP on

On March 6, 2020, the United States Trade Representative (“USTR”) issued product exclusions pertaining to the 7.5% Section 301 List 4A Tariffs. The new list of exclusions includes 8 10-digit HTS subheadings that cover 59...more

21 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide